Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-21
1999-08-03
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
059326115
ABSTRACT:
The present invention provides a treatment for angiogenic diseases, including solid tumors. The treatment consists of administering therapeutically active dosages of FC101, resulting in a reduction in endothelial cell proliferation and inhibition of new blood vessel formation. FC101 can also be used as a lead compound to develop other pharmacologically-active compounds, by adding or substituting different functional groups for those already present on the FC101 molecule.
REFERENCES:
W. Xie et al., "Isolation and structure identification of two new derivatives of the mycotoxin fusarochromenone produced by Fusarium equiseti," J Nat Prod 1995; 58:124-7.
J. C. Kim et al., "Sambutoxin, a new mycotoxin produced by toxic Fusarium isolates obtained from rotted potato tubers," Appl Environ Microbiol 1994; 60:4380-6.
M. W. Orth et al., "Avian tibial dyschondroplasia: a morphological and biochemical review of the growth plate lesion and its causes," Vet Pathol 1994;31:403-414.
M. E. Cook et al., "Factors influencing growth plate cartilage turnover," Poult Sci 1994; 73:889-96.
W. Wu et al., "Tibial dyschondroplasia of chickens induced by fusarochromanone, a mycotoxin," Avian Dis 1993; 37:302-9.
F. Minervini et al., "Immunomodulatory effects of fusarochromanones TDP-1 and TDP-2," Nat Toxins 1992; 1:15-18.
R. J. Pawlosky et al.,"Mass spectral analysis and fragment ion structure of fusarochromanone, "Biol Mass Spectrometry 1991; 20:743-9.
J. Yu et al., "Immunochromatography of fusarochromanone mycotoxins," J Assoc Off Anal Chem 1991; 74:655-60.
W. Wu et al., "Fusarochromanone production by Fusarim isolates," Appl Environ Microbiol 1990; 56:2989-93.
C. J. Mirocha et al., "Absence of trichothecenes in toxigenic isolates of Fusarium moniliforme," Appl Environ Microbiol 1990; 56:520-5.
J. S. Haynes et al., "Ultrastructure of Fusarium-induced tibial dyschondroplasia in chickens: a sequential study," Vet Pathol 1986; 23:499-505.
H. K. Abbas et al., "Mycotoxins produced by toxic Fusarium isolates obtained from agricultural and nonagricultural areas (Arctic) of Norway," Mycopathologia 1989; 105:143-51.
P. Krogh et al., "Natural occurrence of the mycotoxin fusarochromanone, a metabolite of Fusarium equiseti, in cereal feed associated with tibial dyschondroplasia," Appl Environ Microbiol 1989; 55:3184-8.
H. K. Abbas et al., "Production of trichothecene and non-trichotecence mycotoxins by Fusarium species isolated from maize in Minnesota," Mycopathologia 1989; 108:55-8.
W. Xie et al., "Biosynthesis of fusarochromanone and its monoacetyl derivative by Fusarium equiseti," Appl Environ Microbiol 1989; 55:794-7.
C. J. Mirocha et al., "Mycotoxin production by Fusarium oxysporum and Fusarium sporotrichioides isolated from Baccharis spp. from Brazil," Appl Environ Microbiol 1989; 55:254-5.
E. M. Lawler et al., "Acid phosphatase activity of chondroclasts from Fusarium-induced tibial dyschondroplastic cartilage," Avian Dis 1988; 32:240-5.
M. M. Walser et al., "Effect of dietary selenium on the development of Fusarium-induced tibial dyschondroplasia in broiler chickens," Avian Dis 1988; 32:84-8.
G. C. Wright, Jr. et al., "Effect of fusarochromanone and T-2 toxin on articular chondrocytes in monolayer culture," Fundam Appl Toxicol 1987; 9:595-7.
J. Yu et al.,"Production and characterization of antibody against fusarochromanone," Food & Agricult Immun 1990; 2:55-64.
Daotai Nie et al., "Defect in Formation of Functional Matrix Vesicles by Growth Plate Chondrocytes in Avian Tibial Dyschondroplasia: Evidence of Defective Tissue Vascularization," Journal of Bone and Mineral Research 1995; 10:1625-1634.
Sadanand V. Pathre et al., "The structure of fusarochromanone: new mycotoxin from Fusarium roseum, "Graminearum"," Can. J. Chem. 1986; 64:1308-1311.
Shannon Brownlee, "They called his theory ridiculous," U.S. New & World Report 1996, p. 82.
Yin-won Lee et al., "TDP-1, a Toxic Component Causing Tibial Dyschondroplasia in Broiler Chickens, and Trichothecenes from Fusarium roseum `Graminearum`," Applied and Environmental Microbiology 1985; pp. 102-106.
Pathre et al., Can. J. Chem., 64(7), 1308-11 Abatract Only, 1986.
Nie Daotai
Wuthier Roy E.
Goldberg Jerome D.
University of South Carolina
LandOfFree
Angiogenesis inhibitor for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenesis inhibitor for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitor for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849897